{"id":"https://openalex.org/W1998698366","doi":"https://doi.org/10.1097/qad.0b013e3283584500","title":"Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies","display_name":"Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies","publication_year":2012,"publication_date":"2012-07-28","ids":{"openalex":"https://openalex.org/W1998698366","doi":"https://doi.org/10.1097/qad.0b013e3283584500","mag":"1998698366","pmid":"https://pubmed.ncbi.nlm.nih.gov/22842995"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0b013e3283584500","doi":"https://doi.org/10.1097/qad.0b013e3283584500","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283584500","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/20.500.11940/2424","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012684643","display_name":"Lourdes Anta","orcid":"https://orcid.org/0000-0001-5981-1850","observed_orcids":["https://orcid.org/0000-0001-5981-1850"]},"institutions":[{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Lourdes Anta","raw_affiliation_strings":["Infectious Diseases Department, Hospital Carlos III, Madrid, Spain. lourdes.anta@hotmail.es","Infectious Diseases Department, Hospital Carlos III, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Department, Hospital Carlos III, Madrid, Spain. lourdes.anta@hotmail.es","institution_ids":["https://openalex.org/I4387152292"]},{"raw_affiliation_string":"Infectious Diseases Department, Hospital Carlos III, Madrid","institution_ids":["https://openalex.org/I4387152292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029931096","display_name":"Josep Maria Llibre","orcid":"https://orcid.org/0000-0002-7158-6753","observed_orcids":["https://orcid.org/0000-0002-7158-6753"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep M. Llibre","raw_affiliation_strings":["Hospital Universitari Germans Trias i Pujol-Fundaci\u00f3 Lluita contra la SIDA, Badalona-Universitat Aut\u00f2noma, Barcelona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Germans Trias i Pujol-Fundaci\u00f3 Lluita contra la SIDA, Badalona-Universitat Aut\u00f2noma, Barcelona","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057854777","display_name":"Eva Poveda","orcid":"https://orcid.org/0000-0003-4835-9875","observed_orcids":["https://orcid.org/0000-0003-4835-9875"]},"institutions":[{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Poveda","raw_affiliation_strings":["Infectious Diseases Department, Hospital Carlos III, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Department, Hospital Carlos III, Madrid","institution_ids":["https://openalex.org/I4387152292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109989205","display_name":"Jos\u00e9 L Blanco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 L. Blanco","raw_affiliation_strings":["Hospital Cl\u00ednic, Barcelona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Cl\u00ednic, Barcelona","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103423462","display_name":"Marta \u00c1lvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta \u00c1lvarez","raw_affiliation_strings":["Hospital San Cecilio, Granada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital San Cecilio, Granada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042565417","display_name":"Mar\u00eda Jes\u00fas P\u00e9rez-El\u00edas","orcid":"https://orcid.org/0000-0001-5700-5257","observed_orcids":["https://orcid.org/0000-0001-5700-5257"]},"institutions":[{"id":"https://openalex.org/I4210127475","display_name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria","ror":"https://ror.org/03fftr154","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127475"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda J. P\u00e9rez-El\u00edas","raw_affiliation_strings":["Hospital Ram\u00f3n y Cajal-IRyCIS, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Ram\u00f3n y Cajal-IRyCIS, Madrid","institution_ids":["https://openalex.org/I4210127475","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068966782","display_name":"Antonio Aguilera","orcid":"https://orcid.org/0000-0001-6940-241X","observed_orcids":["https://orcid.org/0000-0001-6940-241X"]},"institutions":[{"id":"https://openalex.org/I4210166479","display_name":"Hospital Provincial de Conxo","ror":"https://ror.org/01rf07780","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210166479"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Aguilera","raw_affiliation_strings":["Hospital de Conxo-CHUS, Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital de Conxo-CHUS, Santiago de Compostela","institution_ids":["https://openalex.org/I4210166479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109866020","display_name":"Estrella Caballero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Estrella Caballero","raw_affiliation_strings":["Hospital Vall d\u2019Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Vall d\u2019Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009751300","display_name":"Vincent Soriano","orcid":"https://orcid.org/0000-0002-4624-5199","observed_orcids":["https://orcid.org/0000-0002-4624-5199"]},"institutions":[{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vicente Soriano","raw_affiliation_strings":["Infectious Diseases Department, Hospital Carlos III, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Department, Hospital Carlos III, Madrid","institution_ids":["https://openalex.org/I4387152292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019171058","display_name":"Carmen de Mendoza","orcid":"https://orcid.org/0000-0001-5224-7492","observed_orcids":["https://orcid.org/0000-0001-5224-7492"]},"institutions":[{"id":"https://openalex.org/I4387152292","display_name":"Carlos III Hospital","ror":"https://ror.org/05ntpq911","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746","https://openalex.org/I4387152292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen de Mendoza","raw_affiliation_strings":["Infectious Diseases Department, Hospital Carlos III, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Department, Hospital Carlos III, Madrid","institution_ids":["https://openalex.org/I4387152292"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5012684643"],"corresponding_institution_ids":["https://openalex.org/I4387152292"],"apc_list":null,"apc_paid":null,"fwci":7.1531,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.97716172,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"27","issue":"1","first_page":"81","last_page":"85"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rilpivirine","display_name":"rilpivirine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hiv-drug-resistance","display_name":"HIV drug resistance","score":0.5809999704360962},{"id":"https://openalex.org/keywords/resistance-associated-mutations","display_name":"resistance-associated mutations","score":0.8709999918937683},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8220000267028809},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":1.0},{"id":"https://openalex.org/keywords/etravirine","display_name":"etravirine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9200000166893005},{"id":"https://openalex.org/keywords/y181c","display_name":"Y181C","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2778723075","wikidata":"https://www.wikidata.org/wiki/Q421547","display_name":"Rilpivirine","level":5,"score":0.9716865420341492},{"id":"https://openalex.org/C2780345285","wikidata":"https://www.wikidata.org/wiki/Q414762","display_name":"Etravirine","level":5,"score":0.9255445599555969},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.8836917877197266},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.8365060091018677},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6395483016967773},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6282390356063843},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.5611551403999329},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.528615415096283},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5066133737564087},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.43249544501304626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3789810538291931},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34720999002456665},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24252066016197205},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.22077181935310364},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19651943445205688},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.1477324366569519},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.10442802309989929},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09258222579956055},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08159300684928894}],"mesh":[{"descriptor_ui":"D000068696","descriptor_name":"Rilpivirine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/qad.0b013e3283584500","doi":"https://doi.org/10.1097/qad.0b013e3283584500","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3283584500","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:22842995","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22842995","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"},{"id":"pmh:oai:dnet:runa________::c432572654a4567f7491b8ccb669b030","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.11940/2424","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:runa.sergas.gal:20.500.11940/2424","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.11940/2424","pdf_url":null,"source":{"id":"https://openalex.org/S4306402506","display_name":"RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210158352","host_organization_name":"Servicio Gallego de Salud","host_organization_lineage":["https://openalex.org/I4210158352"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dnet:runa________::c432572654a4567f7491b8ccb669b030","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.11940/2424","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1987693019","https://openalex.org/W2046784753","https://openalex.org/W2058498750","https://openalex.org/W2075029974","https://openalex.org/W2084302660","https://openalex.org/W2099826019","https://openalex.org/W2120602370","https://openalex.org/W2122676482","https://openalex.org/W2137695643","https://openalex.org/W2142538462","https://openalex.org/W2155661911","https://openalex.org/W2328594556","https://openalex.org/W2916981229","https://openalex.org/W2917997753","https://openalex.org/W4236479494","https://openalex.org/W6630897105"],"related_works":["https://openalex.org/W4403948751","https://openalex.org/W2343286258","https://openalex.org/W2130758799","https://openalex.org/W2131787297","https://openalex.org/W159331612","https://openalex.org/W2802802304","https://openalex.org/W1861169541","https://openalex.org/W2138605719","https://openalex.org/W2045698878","https://openalex.org/W2323342869"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Rilpivirine":[1],"(RPV)":[2],"is":[3,23,215,227],"the":[4,27,163],"latest":[5],"approved":[6],"nonnucleoside":[7],"reverse":[8],"transcriptase":[9],"inhibitor":[10],"(NNRTI).":[11],"It":[12,226],"displays":[13],"in-vitro":[14],"activity":[15],"extending":[16],"over":[17],"other":[18,37,224],"NNRTI-resistant":[19],"HIV":[20,49],"strains.":[21],"There":[22],"scarce":[24],"information":[25],"about":[26],"rate":[28],"of":[29,68,86,202,221],"RPV":[30,40,87,185,194,213],"resistance-associated":[31],"mutations":[32],"(RAMs)":[33],"in":[34,44,60,120,133,197,218,245],"patients":[35,50,70,134,172,188,222],"failing":[36,71,135,173,223],"NNRTIs.":[38,225],"METHODS:":[39],"RAMs":[41,88],"were":[42,82,123,129,154,182],"examined":[43],"plasma":[45],"samples":[46],"collected":[47],"from":[48,65,171],"that":[51],"had":[52],"recently":[53],"failed":[54],"NNRTI-based":[55],"regimens":[56],"at":[57],"22":[58],"clinics":[59],"Spain.":[61],"RESULTS:":[62],"Resistance":[63],"tests":[64],"a":[66],"total":[67],"1064":[69],"efavirenz":[72],"(EFV)":[73],"(54.5%),":[74],"nevirapine":[75],"(NVP)":[76],"(40%)":[77],"or":[78,233],"etravirine":[79],"(ETR)":[80],"(5.5%)":[81],"examined.":[83],"The":[84],"prevalence":[85],"was":[89,118,195],"K101E":[90],"(9.1%),":[91],"K101P":[92],"(1.4%),":[93],"E138A":[94],"(3.9%),":[95],"E138G":[96],"(0.3%),":[97,99],"E138K":[98],"E138Q":[100],"(0.8%),":[101],"V179L":[102],"(0.2%),":[103,109],"Y181C":[104,203],"(21.8%),":[105],"Y181I":[106],"(0.5%),":[107],"Y181V":[108],"H221Y":[110,151],"(8.3%),":[111],"F227C":[112],"(0.1%)":[113],"and":[114,127,142,152,179,209],"M230L":[115],"(1.5%).":[116],"K101E/M184I":[117],"seen":[119,196,244],"1%.":[121],"E138K/M184I":[122],"absent.":[124],"Mutations":[125],"L100I":[126],"V108I":[128,210],"significantly":[130],"more":[131,155,228],"frequent":[132],"EFV":[136,160,177,238],"than":[137,159,237],"NVP":[138,158,234],"(7.9":[139],"vs.":[140,144],"0.2":[141],"12.2":[143],"7.3%,":[145],"respectively).":[146],"Conversely,":[147],"Y181C,":[148],"Y181I,":[149],"V106A,":[150],"F227L":[153],"prevalent":[156],"following":[157,230],"failures.":[161],"Using":[162],"Spanish":[164],"resistance":[165,214],"interpretation":[166],"algorithm,":[167],"206":[168],"genotypes":[169],"(19.3%)":[170],"NNRTI":[174],"(NVP":[175],"52%,":[176],"40.8%":[178],"ETR":[180,190,231],"7.8%)":[181],"considered":[183],"as":[184,200],"resistant.":[186],"In":[187],"with":[189],"failure,":[191],"cross-resistance":[192],"to":[193],"27.6%,":[198],"mainly":[199],"result":[201],"(81.3%),":[204],"V179I":[205],"(43.8%),":[206],"V90I":[207],"(31.3%)":[208],"(18.8%).":[211],"CONCLUSION:":[212],"overall":[216],"recognized":[217],"nearly":[219],"20%":[220],"common":[229],"(27.6%)":[232],"(25%)":[235],"failures":[236],"(14.5%).":[239],"E138":[240],"mutants":[241],"are":[242],"rarely":[243],"this":[246],"context.":[247]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}